摘要:
The present invention relates to a method for preparing nonlamellar bioresorbable microparticles to which protein substances are bonded, characterized in that it comprises the steps of: (i) preparing said microparticles from at least one bioresorbable polymer without stabilizer and without surfactant, and (ii) bonding said protein substances to the microparticles obtained in step (i) without surfactant. It further relates to the bioresorbable microparticles thus obtained and use thereof in diagnosis and therapy.
摘要:
Viral material, in the isolated or purified state, in which the genome comprises a nucleotide sequence chosen from the group including sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, their complementary sequences and their equivalent sequences, in particular nucleotide sequences displaying, for any succession of 100 contiguous monomers, at least 50% and preferably at least 70% homology with the said sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, respectively, and their complementary sequences.
摘要翻译:分离或纯化状态的病毒物质,其中基因组包含选自SEQ ID NO:46,SEQ ID NO:51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:53的核苷酸序列 SEQ ID NO:46,SEQ ID NO:56,其互补序列及其等同序列,特别是核苷酸序列,显示100个连续单体的任何连续序列,与所述序列SEQ ID NO:46,SEQ ID NO:至少50%,优选至少70% :51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:56及其互补序列。
摘要:
The present invention relates to a method for preparing nonlamellar bioresorbable microparticles to which protein substances are bonded, characterized in that it comprises the steps of: (i) preparing said microparticles from at least one bioresorbable polymer without stabilizer and without surfactant, and (ii) bonding said protein substances to the microparticles obtained in step (i) without surfactant. It further relates to the bioresorbable microparticles thus obtained and use thereof in diagnosis and therapy.
摘要:
The invention concerns a method for HVC virus culture in vitro comprising steps which consist in: contacting particles containing hepatitis C virus RNA with cells capable of synthesizing and secreting lipoproteins, in a suitable culture environment promoting synthesis and secretion of lipoproteins, and in collecting the virus thus obtained. The invention has diagnostic and therapeutic applications.
摘要:
The nucleotide sequence of Tc100, a gene encoding a new antigenic protein from Trypanosoma cruzi called PTc100, is disclosed. The amino acid sequence of the PTc100 protein is also disclosed, along with the amino acid sequence of the dominant antigenic epitope of the PTc100 protein. The PTc100 protein and Tc100 gene, or a fragment thereof, modified or otherwise, can be used directly or indirectly for the detection of Trypanosoma cruzi, or for the monitoring of an infection generated by T. cruzi in man or animals.
摘要:
Viral material, in the isolated or purified state, in which the genome comprises a nucleotide sequence chosen from the group including sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, their complementary sequences and their equivalent sequences, in particular nucleotide sequences displaying, for any succession of 100 contiguous monomers, at least 50% and preferably at least 70% homology with the said sequences SEQ ID NO:46, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:56, respectively, and their complementary sequences.
摘要翻译:分离或纯化状态的病毒物质,其中基因组包含选自SEQ ID NO:46,SEQ ID NO:51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:53的核苷酸序列 SEQ ID NO:46,SEQ ID NO:56,其互补序列及其等同序列,特别是核苷酸序列,显示100个连续单体的任何连续序列,与所述序列SEQ ID NO:46,SEQ ID NO为至少50%,优选至少70% :51,SEQ ID NO:52,SEQ ID NO:53和SEQ ID NO:56及其互补序列。
摘要:
An isolated polynucleotide having a nucleotide sequence selected from the group consisting of (a) SEQ ID NO: 21, (b) the full-length sequences encoding a polypeptide having a peptide sequence selected from the group consisting of SEQ ID NOs: 25 and 26, and (c) the full-length complementary sequences to the sequences set forth in (a) or (b).
摘要翻译:一种分离的多核苷酸,其具有选自(a)SEQ ID NO:21,(b)编码具有选自SEQ ID NO:25和26的肽序列的多肽的全长序列的核苷酸序列 ,和(c)与(a)或(b)中列出的序列的全长互补序列。
摘要:
The present invention concerns a method for decontaminating a solution of any nucleic acid present in said solution, comprising the following steps: for a sufficient period, subjecting the solution to the action of at least one type of molecule having the property of degrading the nucleic acids by fragmentation, termed a fragmentation molecule, until said nucleic acids, termed contaminating nucleic acids, have been completely degraded; and stopping the activity of the fragmentation molecule. The invention also concerns the use of said treated solution.The preferred application of the invention is in the field of diagnostics.
摘要:
The invention concerns an endogenic nucleic fragment, such as an isolated retrovirus, integrated in the human DNA genome, the fragment being characterized in that it comprises, or consists of, at least part of the gag gene of an endogenetic retrovirus associated with an autoimmune disease or pregnancy failure or pregnancy pathologies, said part at least coding, directly and indirectly, for an expression product, or the complement of the fragment.
摘要:
The invention provides viral material and nucleotide fragments associated with multiple sclerosis and/or rheumatoid arthritis for use in methods of diagnosis, prophylaxis, and therapy.